Ovarian Cancer Clinical Trials

Showing 841-860 of 993 trials

Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT00267696

The purpose of this study is to test the effectiveness, safety and tolerability of the drug combination: gemcitabine, carboplatin and bevacizumab in patients that have been diagnosed with platinum sensitive recurrent ovarian cancer, fallopian tube or primary peritoneal cancer.

Ovarian CancerFallopian Tube CancerPeritoneal Cancer

Ohio State University Comprehensive Cancer Center45 participantsStarted Nov 2005

Columbus, Ohio, United States

COMPLETEDPhase 1

Immunotoxin Therapy in Treating Patients With Advanced Cancer

NCT00006981

RATIONALE: Immunotoxins can locate tumor cells and kill them without harming normal cells. Immunotoxin therapy may be an effective treatment for advanced cancer. PURPOSE: Phase I trial to study the effectiveness of immunotoxins in treating patients who have advanced cancer.

Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more

National Cancer Institute (NCI)Started Dec 2000

Bethesda, Maryland, United States

COMPLETEDPhase 1

Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors

NCT00020150

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining temozolomide and O6-benzylguanine in treating children who have solid tumors that have not responded to previous therapy.

Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more

National Cancer Institute (NCI)Started Jun 2000

Bethesda, Maryland, United States

Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors

Related Searches

Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer

Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer

Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer

A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer

Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors

Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer

Pilot Study of IV and IP Chemotherapy Plus Abdominal Hyperthermia for Ovarian Ca

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer

Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin

Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer

Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer

A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer